Activated microglial cells produce the pro-inflammatory mediators such as nitric oxide (NO) and cytokines. The excessive release of these mediators can lead to neurodegenerative diseases, such as Alzheimer's disease (AD) and Parkinson's disease (PD). Inhibition of the release of these pro-inflammatory molecules may prevent or halt the progression of these diseases. Plumbagin (PL), a naphthoquinone compound in the roots of the traditional medicinal plant Plumbago zeylanica L., showed anti-inflammatory effects on macrophages. However, PL effects on activated microglia remain unknown. In the present study, PL has been examined for its anti-inflammatory effect on LPS -activated microglial BV-2 cells. In this study, NO and iNOS expression were investigated in BV-2 microglial cells in the presence of PL or the selective iNOS inhibitor L-N6-(1-iminoethyl) lysine (L-NIL). The results obtained indicate that PL was > 30-fold potent than L-NIL in inhibiting NO production with an IC 50 of 0.39 μM. Our immunofluorescence study confirmed the ability of PL to significantly inhibit iNOS expression in the activated microglia. Furthermore, the extracellular microglial pro-inflammatory cytokine expression in the presence of 2 μM of PL was detected, quantified, and validated using cytokine antibody protein arrays and quantitative ELISA. The results obtained showed that PL significantly downregulated the expression of many cytokines including IL-1α, G-CSF, IL-12 p40/p70, MCP-5, MCP-1, and IL-6. In conclusion, PL potency in attenuating multiple pro-inflammatory agents indicates its potential to be used for neurodegenerative diseases.
Introduction
In the central nervous system, the immune system plays a critical role in sustaining tissues homeostasis in response to external influences such as infection and injury (Glass et al., 2010) . Microglial cells are the major resident immune cells in the CNS, with a resting phenotype under normal conditions (Streit, 2002) . However, upon infection or neuronal injury, microglial cells become active, proliferate, and move to the injured area (Kettenmann et al., 2011) . The activated microglia produce cytotoxic pro-inflammatory molecules such as nitric oxide (NO) and cytokines/chemokines. These events are common in many chronic inflammatory neurodegenerative diseases. The most common of these diseases include Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and Huntington's disease (HD) (Block and Hong, 2007; Lull and Block, 2010) .
Cellular expression of several pro-inflammatory molecules is stimulated by nuclear factor қB (NF-қB) (Kielian, 2006) . Hence, the inhibition of active NF-қB is considered to be a significant target for antiinflammatory drugs (Tak and Firestein, 2001) . Moreover, numerous studies examined the anti-inflammatory and neuroprotective effects of the bicyclic naphthoquinone plumbagin (PL) (5-hydroxy-2-methyl-1, 4-naphthoquinone). Several investigations showed that PL inhibits NF-қB (Checker et al., 2009; Luo et al., 2010; T. Wang et al., 2014; Zhang et al., 2015) and the pro-inflammatory cytokines stimulated by NF-κB activation in the in vivo models of osteoporosis (Zheng et al., 2017) . Furthermore, the protective effects of PL through inhibition of LPS-induced NO, cytokines and NF-қB release in mice and RAW 264.7 macrophage cells were reported (Checker et al., 2014; T. Wang et al., 2014) .
The natural compound PL is the main active constituent of the medicinal plant Plumbago zeylanica that showed anti-inflammatory effects (Sheeja et al., 2010) . Plumbago zeylanica roots had been used in India for many centuries in treating skin diseases, diarrhea, dyspepsia, piles, anasarca, plague, leprosy, urinary tract infections, scabies and ulcers (Jetty et al., 2010) . The plant extract was found to have neuroprotective, hepatoprotective antiatherogenic, and cardiotonic properties (Tilak et al., 2004) . PL is found in other medicinal plants belonging to the Plumbaginaceae, Droseraceae, and Ebenaceae families (Khaw et al., 2015) . Recently, many studies evaluated the medicinal 
